These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11171510)

  • 41. Pasireotide for malignant insulinoma.
    Tirosh A; Stemmer SM; Solomonov E; Elnekave E; Saeger W; Ravkin Y; Nir K; Talmor Y; Shimon I
    Hormones (Athens); 2016 Apr; 15(2):271-276. PubMed ID: 26732164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant insulinoma with extensive liver metastases presenting as disturbance of consciousness.
    Toyoda C; Hosokawa K; Atsumi Y; Asahina S; Shimada A; Mokubo A; Matsuoka K; Morinaga S; Hayashi F; Hikita M; Tomonari H; Kuriyama S; Inoue K; Hosoya T
    Intern Med; 1998 May; 37(5):476-9. PubMed ID: 9652905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Everolimus dramatically improves glycemic control in unresectable metastatic insulinoma: a case report.
    Asayama M; Yamada-Murano T; Hara H; Ooki A; Kurosumi M; Yamaguchi K
    Jpn J Clin Oncol; 2014 Feb; 44(2):186-90. PubMed ID: 24367043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of hepatic arterial embolisation in the treatment for metastatic insulinoma. Report of two cases and review of the literature.
    Berwaerts J; Verhelst J; Hubens H; Kunnen J; Schrijvers D; Joosens E; Mahler C; Van Gaal L
    Acta Clin Belg; 1997; 52(5):263-74. PubMed ID: 9489120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
    Termanini B; Gibril F; Doppman JL; Reynolds JC; Stewart CA; Sutliff VE; Venzon DJ; Jensen RT
    Radiology; 1997 Jan; 202(1):151-8. PubMed ID: 8988205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful control of intractable hypoglycemia using radiopharmaceutical therapy with strontium-89 in a case with malignant insulinoma and bone metastases.
    Naganuma A; Mayahara H; Morizane C; Ito Y; Hagihara A; Kondo S; Ueno H; Itami J; Okusaka T
    Jpn J Clin Oncol; 2012 Jul; 42(7):640-5. PubMed ID: 22525212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant insulinoma in ectopic pancreatic tissue.
    Hennings J; Garske U; Botling J; Hellman P
    Dig Surg; 2005; 22(5):377-9. PubMed ID: 16432300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver transplantation for hepatic metastatic pancreatic insulinoma with a survival over five years.
    Chen XB; Yang J; Xu MQ; Yan LN
    Chin Med J (Engl); 2012 Aug; 125(15):2768-71. PubMed ID: 22931990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metastatic Insulinoma Controlled by Targeted Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Solitary Kidney and MEN-1 Syndrome.
    Novruzov F; Mehmetbeyli L; Aliyev JA; Abbasov B; Mehdi E
    Clin Nucl Med; 2019 Jun; 44(6):e415-e417. PubMed ID: 30789400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [X-ray diagnostic strategies in liver and pancreatic tumors].
    Langer R; Felix R
    Rontgenblatter; 1989 Sep; 42(9):370-7. PubMed ID: 2552564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of multiple hepatic metastases of gastrinoma not apparent on CT by In-111 octerotide scintigraphy.
    McInerney GF; Carmalt H; MaGee M; Allman K; van der Wall H
    Clin Nucl Med; 1996 Sep; 21(9):730-1. PubMed ID: 8879876
    [No Abstract]   [Full Text] [Related]  

  • 52. Scintigraphic diagnosis of insulinoma in a dog.
    Lester NV; Newell SM; Hill RC; Lanz OI
    Vet Radiol Ultrasound; 1999; 40(2):174-8. PubMed ID: 10225531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma.
    Arslan MS; Ozbek M; Karakose M; Tutal E; Ucan B; Yilmazer D; Dilli A; Gultekin SS; Cakal E; Delibasi T
    Arch Endocrinol Metab; 2015 Jun; 59(3):270-2. PubMed ID: 26154097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulinoma associated with liver lesions: value of MR imaging.
    Vandevenne JE; Deckers F; Mana F; Küçükaycan M; d'Archambeau O; De Schepper AM
    Am J Gastroenterol; 1998 Sep; 93(9):1559-62. PubMed ID: 9732946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A 42-year-old patient with a metastasizing insulinoma].
    Sedlmayr P; Eber B; Kullnig P; Klimpfinger M
    Wien Med Wochenschr; 1987 Jun; 137(12):275-7. PubMed ID: 3039747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Strategy for pancreatic endocrine tumors.
    Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Demachi H; Miwa A
    Hepatogastroenterology; 2000; 47(32):537-9. PubMed ID: 10791232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pregnant patient with hypoglycemia.
    Mannelli L; Yeh MM; Wang CL
    Gastroenterology; 2012 Oct; 143(4):e3-4. PubMed ID: 22921669
    [No Abstract]   [Full Text] [Related]  

  • 59. Scintigraphic depiction of an insulinoma by I-131 metaiodobenzylguanidine.
    Geatti O; Shapiro B; Barillari B
    Clin Nucl Med; 1989 Dec; 14(12):903-5. PubMed ID: 2557999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Symptomatic control of hypoglycaemia with prednisone in refractory metastatic pancreatic insulinoma.
    Novotny J; Janku F; Mares P; Petruzelka L
    Support Care Cancer; 2005 Sep; 13(9):760-2. PubMed ID: 15959811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.